异丙基3,4-二氨基苯甲酸酯 | 121649-61-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 异丙基3,4-二氨基苯甲酸酯
• 英文名称: iso-propyl 3,4-diaminobenzoate
• 英文别名: isopropyl-3,4-diaminobenzoate；3,4-Diaminobenzoic acid isopropyl ester；isopropyl 3,4-diaminobenzoate；propan-2-yl 3,4-diaminobenzoate
• CAS: 121649-61-4
• 化学式: C₁₀H₁₄N₂O₂
• 分子量: 194.233
• InChiKey: CRICWBSRSIVCOV-UHFFFAOYSA-N

物化性质

• 沸点：
  382.5±22.0 °C(Predicted)
• 密度：
  1.175±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  78.3
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险性防范说明：
  P280
• 危险性描述：
  H302,H312,H332

反应信息

• 作为反应物：
  描述：

  异丙基3,4-二氨基苯甲酸酯 在 吡啶 作用下， 以 甲醇 为溶剂， 反应 7.0h， 生成 2-acetylamino-5(6)-isopropoxycarbonylbenzimidazole
  参考文献：
  名称：

  Naim; Singh; Sharma, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1990, vol. 29, # 5, p. 464 - 470

  摘要：

  DOI：
• 作为产物：
  描述：

  iso-propyl 4-amino-3-nitrobenzoate 在 palladium on activated charcoal 、 镍 氢气 作用下， 以 甲醇 为溶剂， 反应 6.0h， 生成 异丙基3,4-二氨基苯甲酸酯
  参考文献：
  名称：

  Naim, S. Shawkat; Singh, Sudhir K.; Sharma, Satyavan, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1988, vol. 27, # 1-12, p. 1106 - 1109

  摘要：

  DOI：

文献信息

• Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
  申请人：Brown R. Truman

  公开号：US20060089316A1

  公开（公告）日：2006-04-27

  Disclosed are methods of using various compounds, which are known to bind to 3-deoxyglucosone (3DG) or precursors thereof, in order to reduce a susceptibility to tumor formation and/or to prevent or delay onset of tumor formation induced by 3DG and its precursors. Also disclosed is the reduction of 3DG levels in high fructose corn syrop so that the high fructose corn syrup is less likely to induce tumor formation.

  公开了使用各种已知与3-脱氧葡萄糖酮（3DG）或其前体结合的化合物的方法，以减少对肿瘤形成的易感性和/或预防或延迟由3DG及其前体诱导的肿瘤形成。还公开了降低高果糖玉米糖浆中3DG水平的方法，以使高果糖玉米糖浆不太可能诱导肿瘤形成。
• Enzymatic method for textile dyeing
  申请人：Novozymes A/S

  公开号：US20010037532A1

  公开（公告）日：2001-11-08

  The present invention relates to methods of dyeing a material which involve contacting the material with a dyeing system which comprises: (a) a mixture of (i) an aromatic diamine and (ii) one or more of a naphthol and an aminonaphthalene and (b) an oxidation system comprising (i) a hydrogen peroxide source and an enzyme exhibiting peroxidase activity or (ii) an enzyme exibiting oxidase activity on one or more of the compounds of mixture (a). The material may be a fabric, yarn, fiber, garment or film made of fur, hide, leather, silk or wool, or made of cationic polysaccharide, cotton, diacetate, flax, linen, lyocel, polyacrylic, synthetic polyamide, polyester, ramie, rayon, triacetate, or viscose.

  本发明涉及一种染色材料的方法，其中涉及将材料与染色系统接触，该染色系统包括：（a）芳香族二胺和萘酚和/或氨基萘之一或多种的混合物；以及（b）氧化系统，其中包括（i）过氧化氢源和表现出过氧化酶活性的酶或（ii）在混合物（a）中的一种或多种化合物上表现出氧化酶活性的酶。该材料可以是毛皮、兽皮、皮革、丝绸或羊毛制成的织物、纱线、纤维、服装或薄膜，或是阳离子多糖、棉、醋酸二乙酯、亚麻、亚麻布、莱赛尔、聚丙烯酸、合成聚酰胺、聚酯、苎麻、人造丝或粘胶制成的织物、纱线、纤维、服装或薄膜。
• Piperidine derivatives having ccr3 antagonism
  申请人：Matsumoto Yoshiyuki

  公开号：US20070032525A1

  公开（公告）日：2007-02-08

  The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C 1 -C 6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

  本发明提供了具有抑制CCR3配体结合到靶细胞CCR3的活性的低分子化合物，即CCR3拮抗剂。本发明还提供了由下式（I）表示的化合物，其药学上可接受的酸加合物或药学上可接受的C1-C6烷基加合物，以及包含它们作为有效成分的制药组合物，用于治疗或预防与CCR3相关的疾病，例如哮喘和过敏性鼻炎。
• PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM
  申请人：TEIJIN LIMITED

  公开号：EP1502916A1

  公开（公告）日：2005-02-02

  The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

  本发明提供了具有抑制 CCR3 配体与靶细胞上 CCR3 结合活性的低分子化合物，即 CCR3 拮抗剂。本发明还提供了下式(I)代表的化合物、其药学上可接受的酸加合物或其药学上可接受的C1-C6烷基加合物，以及包含它们作为有效成分的药物组合物，这些化合物可用于治疗或预防与CCR3相关的疾病，如哮喘和过敏性鼻炎。
• DYEING AGENT AND USE FOR SAME
  申请人：Amano Enzyme Inc.

  公开号：EP2708223A1

  公开（公告）日：2014-03-19

  The object is to provide a process for dyeing that can provide an excellent dyeing effect while utilizing an oxidase, and a dyeing agent for use in the process. Provided is a dyeing agent comprising a modified enzyme obtained by adding positive charge by a chemical modification with an amine to an enzyme selected from the group consisting of an enzyme specified as EC 1.10.3.1, an enzyme specified as EC 1.10.3.2, an enzyme specified as EC 1.3.3.5, an enzyme specified as EC 1.10.3.4, an enzyme specified as EC 1.10.3.3 and an enzyme specified as EC 1.14.18.1. A process for dyeing using the dyeing agent is also provided.

  本发明的目的是提供一种在利用氧化酶的同时能够提供出色染色效果的染色工艺，以及一种用于该工艺的染色剂。本发明提供了一种染色剂，该染色剂包含一种改性酶，该改性酶是通过对选自 EC 1.10.3.1 酶、EC 1.10.3.2 酶、EC 1.3.3.5 酶、EC 1.10.3.4 酶、EC 1.10.3.3 酶和 EC 1.14.18.1 酶组的酶进行胺化学改性而获得正电荷。还提供了一种使用染色剂进行染色的工艺。